Feedback / Questions
nimacimab (RYI-018) - Skye Biosci
https://www.globenewswire.com/news-release/2026/02/02/3230132/0/en/Skye-Reports-Positive-CBeyond-Phase-2a-Extension-Interim-Study-Results-for-Nimacimab-in-Combination-With-Semaglutide.html
Feb 2, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next